Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details)

v3.24.1
Summary of Significant Accounting Policies - Schedule of Disaggregation by Revenue (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Product Information [Line Items]    
Total revenue, net $ 44,384 $ 122,647
Diagnostic services    
Product Information [Line Items]    
Total revenue, net 24,849 108,329
Contract manufacturing    
Product Information [Line Items]    
Total revenue, net 9,400 8,740
Retail and others    
Product Information [Line Items]    
Total revenue, net 2,378 1,281
Genomic products and services    
Product Information [Line Items]    
Total revenue, net $ 7,757 $ 4,297